Profil
Dr. C.
R.
Cory is Global Head-Business Development at biOasis Technologies, Inc.
Dr. Cory was previously employed as Vice President-Business Development by MIGENIX, Inc.
He received his MBA from Wilfrid Laurier University and a doctorate degree from The University of Waterloo.
Anciens postes connus de C. Robert Cory
| Sociétés | Poste | Fin |
|---|---|---|
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 24/03/2010 |
| BIOASIS TECHNOLOGIES INC. | Corporate Officer/Principal | - |
Formation de C. Robert Cory
| The University of Waterloo | Doctorate Degree |
| Wilfrid Laurier University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOASIS TECHNOLOGIES INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |